Invariant NKT cell regulation of autoimmunity

Alberto Molano, Steven A. Porcelli

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Accumulating evidence supports the notion that invariant NKT cells that recognize glycolipids presented by CD1d can play a role in the regulation of certain types of autoimmunity. Focusing mainly on studies of type 1 diabetes and several other common autoimmune diseases, we present an overview of the available knowledge and current speculations on the immunoregulatory mechanisms of NKT cells. Targeting invariant NKT cells with specific glycolipids that bind to CD1d might prove to be a powerful means of modulating autoimmunity.

Original languageEnglish (US)
Pages (from-to)193-198
Number of pages6
JournalDrug Discovery Today: Disease Mechanisms
Volume3
Issue number2
DOIs
StatePublished - 2006

Fingerprint

Natural Killer T-Cells
Autoimmunity
Glycolipids
Type 1 Diabetes Mellitus
Autoimmune Diseases

ASJC Scopus subject areas

  • Drug Discovery
  • Molecular Medicine

Cite this

Invariant NKT cell regulation of autoimmunity. / Molano, Alberto; Porcelli, Steven A.

In: Drug Discovery Today: Disease Mechanisms, Vol. 3, No. 2, 2006, p. 193-198.

Research output: Contribution to journalArticle

@article{f672f204048b4eaa9cd581ef6c69a99c,
title = "Invariant NKT cell regulation of autoimmunity",
abstract = "Accumulating evidence supports the notion that invariant NKT cells that recognize glycolipids presented by CD1d can play a role in the regulation of certain types of autoimmunity. Focusing mainly on studies of type 1 diabetes and several other common autoimmune diseases, we present an overview of the available knowledge and current speculations on the immunoregulatory mechanisms of NKT cells. Targeting invariant NKT cells with specific glycolipids that bind to CD1d might prove to be a powerful means of modulating autoimmunity.",
author = "Alberto Molano and Porcelli, {Steven A.}",
year = "2006",
doi = "10.1016/j.ddmec.2006.05.002",
language = "English (US)",
volume = "3",
pages = "193--198",
journal = "Drug Discovery Today: Disease Mechanisms",
issn = "1740-6765",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Invariant NKT cell regulation of autoimmunity

AU - Molano, Alberto

AU - Porcelli, Steven A.

PY - 2006

Y1 - 2006

N2 - Accumulating evidence supports the notion that invariant NKT cells that recognize glycolipids presented by CD1d can play a role in the regulation of certain types of autoimmunity. Focusing mainly on studies of type 1 diabetes and several other common autoimmune diseases, we present an overview of the available knowledge and current speculations on the immunoregulatory mechanisms of NKT cells. Targeting invariant NKT cells with specific glycolipids that bind to CD1d might prove to be a powerful means of modulating autoimmunity.

AB - Accumulating evidence supports the notion that invariant NKT cells that recognize glycolipids presented by CD1d can play a role in the regulation of certain types of autoimmunity. Focusing mainly on studies of type 1 diabetes and several other common autoimmune diseases, we present an overview of the available knowledge and current speculations on the immunoregulatory mechanisms of NKT cells. Targeting invariant NKT cells with specific glycolipids that bind to CD1d might prove to be a powerful means of modulating autoimmunity.

UR - http://www.scopus.com/inward/record.url?scp=33748514564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748514564&partnerID=8YFLogxK

U2 - 10.1016/j.ddmec.2006.05.002

DO - 10.1016/j.ddmec.2006.05.002

M3 - Article

AN - SCOPUS:33748514564

VL - 3

SP - 193

EP - 198

JO - Drug Discovery Today: Disease Mechanisms

JF - Drug Discovery Today: Disease Mechanisms

SN - 1740-6765

IS - 2

ER -